Chitosan non-particulate vaccine delivery systems
The development of safe and effective vaccines is a major challenge. In addition to generating an adequate immune response, vaccines must also remain stable over time – both inside and outside the body. In their review article, Masimov and Wasan present various applications of chitosan and chitosan derivatives as adjuvants in the development of particulate and non-particulate vaccines.